The Sleep Apnea cardioVascular Endpoints (SAVE) Trial: Rationale, Ethics, Design, and Progress
-
- Nick A. Antic
- The Adelaide Institute for Sleep Health, Repatriation General Hospital, Daw Park, SA, Australia
-
- Emma Heeley
- School of Medicine, Faculty of Medicine, Nursing and Health Sciences, Flinders University, Bedford Park, SA, Australia
-
- Craig S. Anderson
- School of Medicine, Faculty of Medicine, Nursing and Health Sciences, Flinders University, Bedford Park, SA, Australia
-
- Yuanming Luo
- State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
-
- Jiguang Wang
- Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai, China
-
- Bruce Neal
- School of Medicine, Faculty of Medicine, Nursing and Health Sciences, Flinders University, Bedford Park, SA, Australia
-
- Ron Grunstein
- Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
-
- Ferran Barbe
- School of Medicine at the University of Lleida Barcelona, Spain
-
- Geraldo Lorenzi-Filho
- Pulmonary Division - Heart Institute (InCor) University of São Paulo, Brazil
-
- Shaoguang Huang
- Shanghai Rui Jin Hospital, Shanghai, China
-
- Susan Redline
- Department of Medicine and Division of Sleep, Brigham and Women's Hospital and Beth Israel Medical Center, Boston, MA
-
- Nanshan Zhong
- State Key Laboratory of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
-
- R. Doug McEvoy
- The Adelaide Institute for Sleep Health, Repatriation General Hospital, Daw Park, SA, Australia
収録刊行物
-
- Sleep
-
Sleep 38 (8), 1247-1257, 2015-08-01
Oxford University Press (OUP)